D014635Chemicals & DrugsD02.241.081.944.509.900D10.251.400.895.593.90010130.99133Valproic Acidprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25124647Petty SJ, Kantor S, Lawrence KM, Berkovic SF, Collins M, Hill KD, Makovey J, Sambrook PN, O'Brien TJ, Wark JDEpilepsiaPetty SJ, Kantor S, Lawrence KM, Berkovic SF, Collins M, Hill KD, Makovey J, Sambrook PN, O'Brien TJ, Wark JD. Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study. Epilepsia. 2014 Oct; 55(10):1551-7.Epilepsia2014-08-14T00:00:002014Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study.AnesthesiologyNeurologyPathologyWake Forest School of MedicineMarySilviaMary T. Silvia MD36.09003100000000-80.268028000000001140Silvia, MaryClinical Assistant ProfessorJamesEisenachJames C. Eisenach MD36.09003100000000-80.26802800000000269Eisenach, JamesProfessorAnthonyAtalaAnthony Atala MD36.08943500000000-80.268632000000003Atala, AnthonyProfessorJaneBoggsJane G. Boggs MD36.09003100000000-80.26802800000000369Boggs, JaneClinical ProfessorJerriMcLemoreJerri L. McLemore MD36.08959100000000-80.26859900000000446McLemore, JerriAssociate ProfessorNeurology, Pediatric NeurologyUrologyhttp://www.wfirm.orgWFIRM24021575Yoshizumi M, Eisenach JC, Hayashida KThe journal of pain : official journal of the American Pain SocietyYoshizumi M, Eisenach JC, Hayashida K. Valproate prevents dysregulation of spinal glutamate and reduces the development of hypersensitivity in rats after peripheral nerve injury. J Pain. 2013 Nov; 14(11):1485-91.J Pain2013-09-07T00:00:002013Valproate prevents dysregulation of spinal glutamate and reduces the development of hypersensitivity in rats after peripheral nerve injury.true1ProfessorProfessortrue1Clinical ProfessorClinical Professortrue1Clinical Assistant ProfessorClinical Assistant Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor22760542Moschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, Nowakowska B, Phoolchund A, Lay K, Ramasamy TS, Cananzi M, Nettersheim D, Sullivan M, Frost J, Moore G, Vermeesch JR, Fisk NM, Thrasher AJ, Atala A, Adjaye J, Schorle H, De Coppi P, Guillot PVMolecular therapy : the journal of the American Society of Gene TherapyMoschidou D, Mukherjee S, Blundell MP, Drews K, Jones GN, Abdulrazzak H, Nowakowska B, Phoolchund A, Lay K, Ramasamy TS, Cananzi M, Nettersheim D, Sullivan M, Frost J, Moore G, Vermeesch JR, Fisk NM, Thrasher AJ, Atala A, Adjaye J, Schorle H, De Coppi P, Guillot PV. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012 Oct; 20(10):1953-67.Mol Ther2012-07-03T00:00:002012Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.23498565Jones GL, Popli GS, Silvia MTPediatric neurologyJones GL, Popli GS, Silvia MT. Lacosamide-induced valproic acid toxicity. Pediatr Neurol. 2013 Apr; 48(4):308-10.Pediatr Neurol2013-04-01T00:00:002013Lacosamide-induced valproic acid toxicity.23050522Moschidou D, Mukherjee S, Blundell MP, Jones GN, Atala AJ, Thrasher AJ, Fisk NM, De Coppi P, Guillot PVStem cells and developmentMoschidou D, Mukherjee S, Blundell MP, Jones GN, Atala AJ, Thrasher AJ, Fisk NM, De Coppi P, Guillot PV. Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics. Stem Cells Dev. 2013 Feb 01; 22(3):444-58.Stem Cells Dev2012-11-27T00:00:002012Human mid-trimester amniotic fluid stem cells cultured under embryonic stem cell conditions with valproic acid acquire pluripotent characteristics.0.4652670.023377710research area of0.5160510.093136914subject area for